MyFinsight
Home
Blog
About
Contact
Download
Download image
Product
$623,151K
(40.77%↑ Y/Y)
License And Other
Revenues
$251,686K
Total revenues
$874,837K
(94.10%↑ Y/Y)
Income (loss) from
operations
$340,989K
(13508.93%↑ Y/Y)
Total operating
expenses
$533,848K
(17.78%↑ Y/Y)
Income (loss) before
income taxes
$267,391K
(407.51%↑ Y/Y)
Total other expense,
net
-$73,598K
(12.81%↑ Y/Y)
Other income
$12,090K
Selling, general and
administrative
$348,647K
(31.01%↑ Y/Y)
Research and development
$166,126K
(-4.87%↓ Y/Y)
Cost of product sales
$19,075K
(55.47%↑ Y/Y)
Interest income
$10,668K
(-27.65%↓ Y/Y)
Net income (loss)
$263,861K
(396.87%↑ Y/Y)
Income tax expense
$3,530K
(83.19%↑ Y/Y)
Interest expense
$78,872K
(-19.94%↓ Y/Y)
Loss on
extinguishment of debt
-$17,332K
Foreign currency
losses, net
-$152K
(76.29%↑ Y/Y)
Net comprehensive
income (loss)
$262,978K
(394.50%↑ Y/Y)
Total other
comprehensive (loss) income
-$883K
(-112.26%↓ Y/Y)
Foreign currency
translation adjustment
-$674K
(13.14%↑ Y/Y)
Unrealized (loss) gain on
available for sale...
-$209K
(-158.06%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)